World market strategies for drugs to fight AIDS

Jérôme Dumoulin (), Yves-Antoine Flori, Philippe Vinard and Thomas Borel
Additional contact information
Jérôme Dumoulin: LEPII - Laboratoire d'Economie de la Production et de l'Intégration Internationale - UPMF - Université Pierre Mendès France - Grenoble 2 - CNRS - Centre National de la Recherche Scientifique
Yves-Antoine Flori: CREGAS - Centre de recherche en économie et gestion appliquées à la santé - UP1 - Université Paris 1 Panthéon-Sorbonne - UP11 - Université Paris-Sud - Paris 11 - INSERM - Institut National de la Santé et de la Recherche Médicale - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Abstract: Faced with a situation where the market is unstable and the political context is crucial, we propose a three-part analysis. In the first part, an overview of the chronology of the main events shows that the evolution of the price of ARVs is interlinked with numerous issues of pharmaceutical patent rights. In the second part, we analyse the positions of stakeholders : how they behave in the market and influence market regulations. In the third part, we propose three scenarios which are both simplified interpretations of stakeholders' strategies and options for the future. The first scenario is the status quo, where prices are high. The second scenario is driven by multinational companies who work to enlarge the markets by price differentiation and product diversification. The third scenario is driven by International Organisations which achieve a political consensus to enlarge access to ARV drugs through broader international financing and a systematic opening of the market to generics.

Keywords: drug; AIDS; world market; developing countries; price of drugs; médicament; SIDA; marché mondial; prix; industrie pharmaceutique; stratégie; PVD (search for similar items in EconPapers)
Date: 2003
References: Add references at CitEc
Citations:

Published in Moatti, J.P., Coriat, B., Souteyrand, Y., Barnett, T., Dumoulin, J., Flori, Y.A. Economics of AIDS and access to HIV/AIDS care in developing countries : issues and challenges, Agence Nationale de Recherche sur le SIDA, pp.213-244, 2003

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:halshs-00129251

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().